Abstract:With the growth in the use of health economic evaluation to inform healthcare resource allocation decisions, the challenges in applying standard methods to child health have become apparent. A unique limitation is the paucity of child-specific preference-based measures. A single, valid, preference-based measure of utility that can be used in children of all ages does not exist. Thus, the ability to derive a QALY for use in cost-utility analysis (CUA) is compromised. This paper presents and discusses existing and novel options for deriving utilities for paediatric health states for use in CUAs. While a direct elicitation may be preferred, a child's ability to complete a standard gamble or time trade-off task is hampered by cognitive and age limitations. The abstract notions contained in indirect instruments such as the EQ-5D and Health Utilities Index may also pose challenges for young children. Novel approaches to overcome these challenges include the development of age-appropriate instruments such as the EQ-5D-Y, the development of new child-specific utility instruments such as the Child Health Utility-9D and the re-calibration of existing adult instruments to derive preference weights for health states from children themselves. For children aged <6 years, researchers have little choice but to use a proxy reporter such as parents. While parents may be reliable reporters for physical activity limitations and externally manifest symptoms, their ability to accurately report on subjective outcomes such as emotion is questionable. Catalogues of utility weights for a range of conditions are increasingly becoming available but retain many of the same limitations as valuing health states from children or from proxies. Given the dynamic relationship in quality of life (QOL) between family members when a child is ill, it seems appropriate to consider a 'family perspective' rather than an individual perspective in child health state valuation. In a collective approach, health state utilities derived from multiple family members may be combined mathematically. Alternatively, in a unitary approach, a single utility estimate may be determined to represent the family's perspective. This may include deriving utilities through parent-child dyad estimation or by using a household model that combines the utility weights of the patient and family members, incorporating reciprocal QOL effects. While these various approaches to child health state valuation represent novel research developments, the measurement challenges and threats to validity persist. Given the importance of non-health benefits to child health, especially in the domains of education and public policy, it may be worthwhile to consider an approach that allows incorporation of externalities to produce a cost-benefit analysis. The use of discrete-choice methods to assess willingness to pay for novel child health interventions holds promise as a means to produce meaningful economic evidence. Regardless of the approach taken, the highest degree of methodological rigour is essential. The increasing attention being paid by health economic researchers to the measurement challenges of paediatric health state valuation can only increase the value of child health economic evidence for decision making.

Systematic methodological review of health state values in glaucoma cost-utility analyses

Quality Appraisal in Systematic Literature Reviews of Studies Eliciting Health State Utility Values: Conceptual Considerations

Systematic review of utility values used in the pharmacoeconomic evaluations for schizophrenia: implications on cost-effectiveness results

Utility Analysis of Vision-related Quality of Life in Patients with Glaucoma and Different Perceptions from Ophthalmologists

Health-related quality of life in patients with conditions affecting the hand: meta-analysis

Assessment of Vision-Related Quality of Life in Chinese Glaucoma Patients by Utility Analysis

Characteristics of Health-State Utilities Used in Cost-Effectiveness Analyses: a Systematic Review of Published Studies in Asia

Health state utility estimates for value assessments of novel treatments in Huntington's disease: a systematic literature review

Health state utility values of type 2 diabetes mellitus and related complications: a systematic review and meta-regression

A systematic review of health state utility values for older people with acute myeloid leukaemia

Health related quality of life utility weights for economic evaluation through different stages of chronic kidney disease: a systematic literature review

Health state utility values in patients with Ankylosing Spondylitis: a systematic review and meta-analysis

Bayesian Meta-Analysis of Health State Utility Values: A Tutorial with a Practical Application in Heart Failure

Incorporating public and wider stakeholder views in the design of health state valuation studies in adults and young people: an undervalued resource?

Health state utility values in major depressive disorder treated with pharmacological interventions: a systematic literature review

Systematic review of economic evaluations in pediatric ophthalmology and strabismus

Challenges in health state valuation in paediatric economic evaluation: are QALYs contraindicated?

Cost-utility analysis of commonly used anti-glaucoma interventions for mild-to-moderate primary open-angle glaucoma patients in rural and urban China

Systematic Review of Instruments for the Assessment of Patient-Reported Outcomes and Quality of Life in Patients with Childhood Glaucoma

Portable devices for diagnosis and monitoring of glaucoma: a scoping review protocol

A Systematic Review and Meta-Analysis of Health Utility Estimates in Chronic Spontaneous Urticaria